Media Pack
News

Current Edition

Volume 7 Issue 3

Upcoming Events

 

Advertisement

 
 
 
 
Delivering Viable, High-quality Leukapheresis Product via Advanced Cold Storage Solutions
Volume 3 Issue 2

Delivering Viable, High-quality Leukapheresis Product via Advanced Cold Storage Solutions

Fresh leukapheresis product (LP) is a critical raw material in the global biopharmaceutical industry, being essential across many primary cell research and therapy de...
5 October 2020 Volume 3 Issue 2
Continue Reading →
Exosome Therapeutics: Academic Curiosity or Commercial Reality?
Volume 3 Issue 2

Exosome Therapeutics: Academic Curiosity or Commercial Reality?

Cell and gene therapies have been called the emerging fourth pillar of healthcare systems. However, recent research suggests that the cell therapy pillar may, in fact...
5 October 2020 Volume 3 Issue 2
Continue Reading →
Non-clinical Safety Evaluation of Vaccine: Strategic Considerations to Accelerate Clinical Development
Volume 3 Issue 2

Non-clinical Safety Evaluation of Vaccine: Strategic Considerations to Accelerate Clinical Development

Vaccines are medicinal products intended to elicit (an) immune response(s) that can prevent (prophylactic vaccine) and/or lessen the severity (therapeutic vaccine) of...
5 October 2020 Volume 3 Issue 2
Continue Reading →
Accelerating Regenerative Medicine Approaches to Type 1 Diabetes Through Direct Cell Reprogramming
Volume 3 Issue 2

Accelerating Regenerative Medicine Approaches to Type 1 Diabetes Through Direct Cell Reprogramming

Current treatment of type 1 diabetes mellitus (T1DM) depends on the replacement of endogenous insulin by regular subcutaneous injections of exogenous insulin. Unfortu...
5 October 2020 Volume 3 Issue 2
Continue Reading →
Analysing Carbohydrates with Ion Chromatography to Develop Better Vaccines
Volume 3 Issue 2

Analysing Carbohydrates with Ion Chromatography to Develop Better Vaccines

In vaccine research, where reproducibility and accuracy are of paramount importance, scientists will need to choose the most appropriate technique to examine and char...
5 October 2020 Volume 3 Issue 2
Continue Reading →
Unlocking the Therapeutic Potential of Antimicrobial Natural Products with Synthetic Biology
Volume 3 Issue 2

Unlocking the Therapeutic Potential of Antimicrobial Natural Products with Synthetic Biology

Although once a mainstay of drug discovery efforts within the pharmaceutical industry, enthusiasm for the use of natural products as a starting-point for the developm...
5 October 2020 Volume 3 Issue 2
Continue Reading →
Faster Drug Discovery with Picodroplet Technologies
Volume 3 Issue 2

Faster Drug Discovery with Picodroplet Technologies

Automated platforms based on picodroplet microfluidic technologies are one of the most promising tools for improving drug discovery efficiency. By encapsulating singl...
5 October 2020 Volume 3 Issue 2
Continue Reading →
Ensuring Reproducibility in Biomedical Research – The Role of Data, Metadata, and Emerging Best Practices
Volume 3 Issue 2

Ensuring Reproducibility in Biomedical Research – The Role of Data, Metadata, and Emerging Best Practices

Science is built upon continuous cycles of generating hypotheses, testing them, and refining the models based on the findings. Over many years of continuous research,...
5 October 2020 Volume 3 Issue 2
Continue Reading →
Re-programming CHO by Gene Editing, the New Frontier in Bioprocessing
Volume 3 Issue 2

Re-programming CHO by Gene Editing, the New Frontier in Bioprocessing

Since the approval of the first recombinant biotherapeutic, insulin, in 1982, the pharmaceutical industry has experienced an explosion in the development and commerci...
5 October 2020 Volume 3 Issue 2
Continue Reading →
Addressing the Challenges of Selective and Sensitive Bioanalytical Assay Development
Volume 3 Issue 2

Addressing the Challenges of Selective and Sensitive Bioanalytical Assay Development

Antibodies have evolved over millions of years to become a critical component of immunity, but in a few short decades we have dramatically expanded their potential fo...
5 October 2020 Volume 3 Issue 2
Continue Reading →
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte